Skip to content
Doctor writing on a patient's chart

The UroLift™ System

The #1 chosen minimally invasive BPH procedure in the U.S.1 Treat a broad spectrum of anatomies with confidence.2,3

Contact a Urology Consultant

About the Procedure

The UroLift™ System is indicated for the treatment of symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia (BPH), including lateral and median lobe hyperplasia, in men 45 years of age or older.

An enlarged prostate

Enlarged Prostate

An enlarged prostate can narrow or even block the urethra.

Step 1 of the UroLift system

Step 1

The UroLift™ Delivery Device is placed through the obstructed urethra to access the enlarged prostate.

Step 2 of the UroLift system

Step 2

Small UroLift™ Implants are permanently placed to lift and hold the enlarged prostate tissue out of the way.

Step 3 of the UroLift system

Step 3

The UroLift™ Delivery Device is removed, leaving an open urethera to improve flow and provide lasting BPH symptom relief.

Proven Mechanism of Action of the UroLift™ System

  • Only BPH MIST with consistent durability in real world and clinical trials4,5
  • Superior patient experience*  among leading BPH procedures4,6-7
  • An early treatment alternative to BPH medications5
  • One of the most studied BPH MIST with 145+ peer-reviewed and clinical publications and 12,000 patients studied

Treatment with the UroLift™ System does not preclude future UroLift™ System treatments, TURP, or laser procedures.5

Patient Selection

The UroLift™ System provides consistent outcomes to a broad range of BPH patients.8

Prostate Indications for the UroLift™ System✝
Minimum prostate volume None
Maximum prostate volume 100 cc
Obstructive median lobe Yes

The UroLift™ System should not be used if the patient has:

  • Prostate volume of >100 cc
  • A urinary tract infection
  • Urethral conditions that may prevent insertion of a delivery system into the bladder
  • Urinary incontinence due to incompetent sphincter
  • Current gross hematuria

500,000

BPH patients have been treated with the UroLift™ System9

Download IFU

UroLift™ Delivery Devices and Implants

The full line of UroLift™ products are designed for all prostate types.

UroLift 2 system device

UroLift™ 2 System

UroLift 2 System with advanced tissue control

UroLift™ 2 System Advanced Tissue Control

UroLift implant

UroLift™ Implant

Doctor sitting in front of a laptop
“It is our responsibility to educate the patient about all the options. Many of my patients prefer the UroLift™ System procedure over a pill.”
Dr. Robert Cowles+

References

  • 1. U.S. 2022 estimates based on US Market Model 2022-24 (5-17-22 FINAL), which is in part based on Symphony Health PatientSource® 2018-21, as is and with no representations/ warranties, including accuracy or completeness.

  • 2. Rukstalis, Prostate Cancer Prostatic Dis 2018

  • 3. UroLift System Instructions for Use

  • 4. Kaplan, Prostate Cancer Prostatic Dis 2023

  • 5. Roehrborn, Can J Urol 2017

  • 6. Gratzke, BJU Int 2016

  • 7. Tutrone, Can J Urol 2020

  • 8. Eure, J Endourol 2019

  • 9. Management estimate based on product sales as of January 2024. Data on file Teleflex Interventional Urology

  • *Patient experience defined as a combination of rapid symptom relief, low risk profile, and preservation of sexual function

  • † Food and Drug Administration (FDA) patient criteria for the UroLift™ System

  • + Dr. Robert Cowles is a paid consultant of Teleflex

MAC12000-01 Rev B